Skip to main content

Peer Review reports

From: Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial

Original Submission
28 Jul 2015 Submitted Original manuscript
24 Sep 2015 Reviewed Reviewer Report - Martin Haag
25 Sep 2015 Reviewed Reviewer Report - Jiejie Xu
26 Oct 2015 Author responded Author comments - Jifang gong
Resubmission - Version 2
26 Oct 2015 Submitted Manuscript version 2
4 Nov 2015 Reviewed Reviewer Report - JIN LI
11 Nov 2015 Reviewed Reviewer Report - Jiejie Xu
4 Dec 2015 Author responded Author comments - Jifang gong
Resubmission - Version 3
4 Dec 2015 Submitted Manuscript version 3
15 Jan 2016 Author responded Author comments - Jifang gong
Resubmission - Version 4
15 Jan 2016 Submitted Manuscript version 4
Publishing
28 Jan 2016 Editorially accepted
8 Feb 2016 Article published 10.1186/s12885-016-2092-9

You can find further information about peer review here.

Back to article page